The patent relates to a enterically coated cysteamine bitartrate and cystamine composition useful for treating cystinosis and neurodegenerative diseases such as Huntington’s, Alzheimer’s and Parkinson’s disease,
The patent results from a divisional application of EP 1 919 458.
Brief outline of the case
The opposition was rejected and the opponent appealed.